期刊文献+

肝移植治疗淋巴瘤合并慢性乙型病毒性肝炎化疗后急性肝衰竭三例分析 被引量:3

Liver transplantation for acute liver failure in 3 patients with lymphoma complicated with chronic hepatitis B after chemotherapy
原文传递
导出
摘要 目的探讨肝移植治疗淋巴瘤合并慢性乙型病毒性肝炎(慢乙肝)化疗后急性肝衰竭的疗效。方法回顾性分析2009年3月至2014年7月在中山大学附属第三医院接受肝移植的3例淋巴瘤合并慢乙肝化疗后急性肝衰竭患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。3例患者术前诊断为淋巴瘤合并慢乙肝,多次化疗后出现乙型病毒性肝炎(乙肝)重新活动,导致急性肝衰竭。分析3例患者术中、术后免疫抑制方案和抗病毒治疗情况,观察术后淋巴瘤和乙肝复发情况及生存预后。结果 3例患者均急诊行肝移植治疗。患者术后早期免疫抑制方案为他克莫司(FK506)+肾上腺皮质激素(激素),术后3个月及早停用激素,改FK506单药免疫抑制治疗。术后加强抗乙型肝炎病毒治疗,抗病毒方案为恩替卡韦联合乙肝免疫球蛋白。随访至投稿日期,1例患者术后1个月余死于胆道狭窄、感染性休克;余2例恢复良好,未见淋巴瘤和乙肝复发。结论淋巴瘤合并慢乙肝化疗后急性肝衰竭患者行肝移植治疗,术后早期停用激素,加强抗病毒治疗,定期随访,可获得良好的治疗效果。 ObjectiveTo investigate the curative effect of liver transplantation (LT) for acute liver failure in patients with lymphoma complicated with chronic hepatitis B (CHB) after chemotherapy. MethodsClinical data of 3 patients with lymphoma complicated with CHB and acute liver failure after chemotherapy undergoing LT in the Third Afifliated Hospital of Sun Yat-sen University between March 2009 and July 2014 were retrospectively studied. The informed consents of all patients were obtained and the local ethical committee approval had been received. The 3 patients were diagnosed as lymphoma complicated with CHB before operation. Hepatitis B virus (HBV) reactivated after multiple chemotherapies and caused acute liver failure. The intraoperative and postoperative immunosuppressive regimens and antiviral therapy of the patients were analyzed. The recurrence of lymphoma and HBV and survival prognosis after operation were observed.ResultsThe 3 patients underwent emergency LT. The early postoperative immunosuppressive regimen was tacrolimus (FK506) + adrenocortical hormone (hormone). FK506 monotherapy was used when hormone was stopped in 3 months after LT. Anti-HBV treatment was strengthened after LT with the regimen of entecavir combined with hepatitis B immune globulin. The patients were followed up till the date of submission. One patient died of biliary stricture and septic shock 1 month after LT and the other 2 patients recovered well without recurrence of lymphoma and hepatitis B.ConclusionsPatients with lymphoma complicated with CHB and acute liver failure after chemotherapy can achieve favorable curative effect by LT, on condition that hormone is withdrawn early after operation, antivirus treatment is strengthened and regular follow-up is given.
出处 《中华肝脏外科手术学电子杂志》 CAS 2015年第6期368-371,共4页 Chinese Journal of Hepatic Surgery(Electronic Edition)
基金 国家自然科学基金(81370575 81372243 81172036) 十二五科技重大专项(2012ZX10002016-023 2012ZX10002017-005) 广州市科技计划项目(201400000001-3 2014J4100183)
关键词 肝移植 淋巴瘤 肝炎病毒 乙型 肝功能衰竭 急性 Liver transplantation Lymphoma Hepatitis B virus Liver failure,acute
  • 相关文献

参考文献16

  • 1Seetharam A, Perrillo R, Gish R. Immunosuppression in patients withchronic hepatitis B[J]. Curr Hepatol Rep, 2014(13): 235-244.
  • 2Torres HA, Davila M. Reactivation of hepatitis B virus andhepatitis C virus in patients with cancer[J]. Nat Rev Clin Oncol,2012, 9(3):156-166.
  • 3Kim E, Yune S, Ha JM, et al. Hepatitis B virus reactivationdur ing ant i - c anc e r chemothe r apy in pa t i ent s wi th pa s thepatitis B virus infection[J]. Hepatogastroenterology, 2014,61(134):1704-1711.
  • 4Josting A, Wolf J, Diehl V. Hodgkin disease: prognostic factors andtreatment strategies[J]. Curr Opin Oncol, 2000, 12(5):403-411.
  • 5Sperl J, Frankova S, Kieslichova E, et al. Urgent liver transplantationfor chemotherapy-induced HBV reactivation: a suitable option inpatients recently treated for malignant lymphoma[J]. Transplant Proc,2013, 45(7):2834-2837.
  • 6牛建花,杨华,张琪,朱成英,朱海燕,姚子龙,于力,靖彧.HBsAg阳性弥漫大B细胞淋巴瘤化放疗后HBV再激活伴肝衰竭肝移植疗效个例报告[J].中国实验血液学杂志,2014,22(4):1005-1011. 被引量:9
  • 7易述红,易慧敏,傅斌生,牛斌,孟炜,李华,许赤,杨扬,陈规划.肝移植术后新发恶性肿瘤的发生和防治(附九例报告)[J].中华肝脏外科手术学电子杂志,2014,3(3):13-16. 被引量:13
  • 8杨扬,张英才.肝移植术后免疫抑制剂撤退的研究进展[J].器官移植,2013,4(6):320-324. 被引量:4
  • 9Kusumoto S, Tanaka Y, Suzuki R, et al. Monitoring of hepatitis Bvirus (HBV) DNA and risk of HBV reactivation in B-cell lymphoma:a prospective observational study[J]. Clin Infect Dis, 2015, DOI:10.1093/cid/civ344[Epub ahead of print].
  • 10Shouval D, Shibolet O. Immunosuppression and HBV reactivation[J].Semin Liver Dis, 2013, 33(2):167-177.

二级参考文献67

  • 1杨松.非霍奇金淋巴瘤化疗相关HBV感染再激活研究进展[J].中国医学前沿杂志(电子版),2010,2(2):52-55. 被引量:5
  • 2朱莹洁,邢颜超,陈红,唐艺,黄永莉.肝移植术后HBsAg转阴2例[J].临床军医杂志,2006,34(3):395-395. 被引量:1
  • 3朱志军,李林,张雅敏,郑虹,蒋文涛,张建军,高伟,淮明生,沈中阳.肝移植术后新发恶性肿瘤的诊治[J].中华肿瘤杂志,2007,29(3):237-238. 被引量:17
  • 4Roberts MS, Angus DC, Bryce CL, et al. Survival after liver transplantation in the United States: a disease- specific analysis of the UNOS database[J]. Liver Transpl, 2004, 10 (7): 886-897.
  • 5Feng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants [ J ]. JAMA, 2012, 307 (3) : 283 -293.
  • 6Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy [J] . Liver Transpl, 2001, 7 (3): 161-172.
  • 7Tokita D, Mazariegos GV, Zahorchak AF, et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance [J]. Transplantation, 2008, 85 (3): 369-377.
  • 8Orlando G, Manzia T, Baioechi L, et al. The Tot Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months [J]. Transpl Immunol, 2008, 20 (1/2) : 43- 47.
  • 9Sdnchez-Fueyo A. Hot-topic debate on tolerance : immunosuppression withdrawal[J]. Liver Transpl, 2011, 17 (Suppl 3) : $69-$73.
  • 10Starzl TE. The " privileged " liver and hepatic tolerogenicity [ J ] . Liver Transpl, 2001, 7 (10) : 918-920.

共引文献23

同被引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部